Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81380566 | 8138056 | 6 | F | 20110530 | 20160711 | 20110915 | 20160722 | EXP | PHHY2009CA49176 | NOVARTIS | 57.56 | YR | F | Y | 0.00000 | 20160722 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 81380566 | 8138056 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO (EVERY 4 WEEKS) | U | S0037 | 21008 | 20 | MG | VIAL | /month | ||||
| 81380566 | 8138056 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 81380566 | 8138056 | 3 | C | INSULIN | INSULIN NOS | 1 | Unknown | UNK | Y | 0 | |||||||||
| 81380566 | 8138056 | 4 | C | HUMALOG MIX75/25 | INSULIN LISPRO | 1 | Unknown | 22 U, 30 MINTUES BEFORE BREAKFAST AND SUPPER | U | 0 | 22 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 81380566 | 8138056 | 1 | Neuroendocrine carcinoma |
| 81380566 | 8138056 | 2 | Neuroendocrine carcinoma |
| 81380566 | 8138056 | 3 | Product used for unknown indication |
| 81380566 | 8138056 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 81380566 | 8138056 | HO |
| 81380566 | 8138056 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 81380566 | 8138056 | Abdominal discomfort | |
| 81380566 | 8138056 | Abdominal distension | |
| 81380566 | 8138056 | Abdominal pain | |
| 81380566 | 8138056 | Abdominal pain upper | |
| 81380566 | 8138056 | Asterixis | |
| 81380566 | 8138056 | Balance disorder | |
| 81380566 | 8138056 | Biliary dilatation | |
| 81380566 | 8138056 | Blood pressure diastolic decreased | |
| 81380566 | 8138056 | Blood pressure systolic increased | |
| 81380566 | 8138056 | Cholelithiasis | |
| 81380566 | 8138056 | Confusional state | |
| 81380566 | 8138056 | Diarrhoea | |
| 81380566 | 8138056 | Disorientation | |
| 81380566 | 8138056 | Gallbladder enlargement | |
| 81380566 | 8138056 | Gastrointestinal motility disorder | |
| 81380566 | 8138056 | Heart rate increased | |
| 81380566 | 8138056 | Hepatic encephalopathy | |
| 81380566 | 8138056 | Lethargy | |
| 81380566 | 8138056 | Malignant neoplasm progression | |
| 81380566 | 8138056 | Metastases to liver | |
| 81380566 | 8138056 | Musculoskeletal pain | |
| 81380566 | 8138056 | Needle issue | |
| 81380566 | 8138056 | Neoplasm progression | |
| 81380566 | 8138056 | Nephrolithiasis | |
| 81380566 | 8138056 | Pain | |
| 81380566 | 8138056 | Pneumonia | |
| 81380566 | 8138056 | Pulmonary mass | |
| 81380566 | 8138056 | Sepsis | |
| 81380566 | 8138056 | Tachycardia | |
| 81380566 | 8138056 | Telangiectasia | |
| 81380566 | 8138056 | Tenderness | |
| 81380566 | 8138056 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 81380566 | 8138056 | 1 | 20090811 | 0 | ||
| 81380566 | 8138056 | 2 | 20100930 | 0 |